Posters featured in this tour:

PT43: How Has Real-World Evidence Been Leveraged in Non-Oncology Submissions in the UK, France, and Germany? PT44: Prevalence of Comorbidities and Hospitalization in the 65 and over SLE (SYSTEMIC LUPUS ERYTHEMATOSUS) Patient Population: A Comparative Analysis of the FORWARD Lupus Registry and Medicare Data in the US (2017-2021) PT45: Patient Perspective in Endometriosis and Clinical Trial Barriers PT46: Off-Label Use of Semaglutide in the United States: Increasing Prevalence, Variability in Prescribing Provider Specialty, and Patient Characteristics PT47: Prevalence of Systemic Lupus Erythematosus By Social Determinants of Health: Nationally Representative Estimates for 2017-2021 PT48: Using a Database Analysis to Determine Alignment between Physician-Reported and Objectively Derived Fibrosis Scores for US Patients with Metabolic Dysfunction-Associated Steatohepatitis (MASH)